BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu ST, Zhu L, Feng XL, Yang L, Chen GW, Jiang Y, Huang TF, Wang HY, Li F. Advances in neoadjuvant therapy for pancreatic cancer: Current trends and future directions. World J Clin Oncol 2025; 16(6): 105849 [PMID: 40585822 DOI: 10.5306/wjco.v16.i6.105849]
URL: https://www.wjgnet.com/2218-4333/full/v16/i6/105849.htm
Number Citing Articles
1
Maite N.E. Liem, Mats D. Teeken, Mengyuan Ruan, George Molina. Geospatial variation in the treatment of medicare beneficiary pancreatic cancer patients: A SEER-Medicare cohort studyThe American Journal of Surgery 2026; 251: 116684 doi: 10.1016/j.amjsurg.2025.116684
2
Julia Groszewska, Michał Romaniuk, Ewa Małecka-Wojciesko. Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic CancerInternational Journal of Translational Medicine 2025; 5(4): 55 doi: 10.3390/ijtm5040055
3
Symeou Solonas, Lolis D. Evangelos, Glantzounis K. Georgios. Diagnosis and Surgical Management for Advanced Pancreatic Cancer Requiring Vascular ResectionDiagnostics 2025; 16(1): 102 doi: 10.3390/diagnostics16010102